Laboratory Scientist – Automation & Biochemistry (full time)

Netherlands - Amsterdam - Medical Business CentreCompetitiveOn-siteFull time0 applicants

About this role

Laboratory Scientist – Automation & Biochemistry (full time)

Responsibilities

  • Currently living and working within the EU
  • In possession of an EU passport
  • Willing to work onsite in Oss until the move to Amsterdam UMC in early 2027
  • A dynamic, innovative, international working environment, where you can be part of the development of new medicines that can make a difference to patients' lives
  • The opportunity to work in a highly professional, diverse, close-knit team, where you can learn a lot from each other and count on one another
  • The opportunity to further develop yourself, for example, into a position offering even more responsibility

Requirements

  • Competitive salary and secondary benefits including 8% holiday allowance, 27 holidays on a fulltime basis. Additional: office closure between X-mas and New Year + Good Friday.
  • Collective pension with a fixed percentage personal contribution
  • Bonus scheme
  • Vitality of our colleagues is important to us, which is why you can exercise at a discount or make use of our bicycle plan.
  • Support for potential extra travelling costs during the transition period when working at the Oss site

Nice to have

  • Experience working with laboratory automation or robotics systems (Biomeki7).
  • Experience with coding or scripting languages, ideally supporting data handling, assay automation, or process improvement.
  • Background in drug discovery, pharmacology, or related biomedical research.
  • Please note: this role is intended for candidates with a BSc or MSc background. We will not consider candidates that hold a PhD for this role.
  • Important information
  • You are:
  • Currently living and working within the EU
  • In possession of an EU passport
  • Willing to work onsite in Oss until the move to Amsterdam UMC in early 2027
  • Please note: relocation support is not available for this role.
  • What do we offer you?
  • A dynamic, innovative, international working environment, where you can be part of the development of new medicines that can make a difference to patients' lives
  • The opportunity to work in a highly professional, diverse, close-knit team, where you can learn a lot from each other and count on one another
  • The opportunity to further develop yourself, for example, into a position offering even more responsibility
  • Competitive salary and secondary benefits including 8% holiday allowance, 27 holidays on a fulltime basis. Additional: office closure between X-mas and New Year + Good Friday.
  • Collective pension with a fixed percentage personal contribution
  • Bonus scheme
  • Vitality of our colleagues is important to us, which is why you can exercise at a discount or make use of our bicycle plan.
  • Share purchase plan
  • :
  • opportunity to participate in our share purchase plan, with additional contributions from AstraZeneca.
  • Support for potential extra travelling costs during the transition period when working at the Oss site
  • About AstraZeneca Oncology R&D, Amsterdam
  • At AstraZeneca Amsterdam, we bring together two research groups, in haemato-oncology and next-generation cell therapy research. Together, they form our Oncology R&D hub in the Netherlands, working closely with colleagues in the US, Canada, Spain and the UK, to develop innovative treatments for patients with cancer.
  • Our haematology R&D group was born as Acerta Pharma, one of the Netherlands’ greatest biotech success stories. Its small-molecule BTK inhibitor has been approved by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). In Amsterdam approximately 100 colleagues continue the development of new therapies for haematological malignancies under the AstraZeneca brand name.
  • AstraZeneca’s Cell Therapy R&D team focuses on developing next-generation T-cell receptor (TCR) therapies targeting neoantigens in solid tumors. With a team of around 75 scientists, we work on both fully individualized and shared neo-antigen approaches, with the aim of improving outcomes for patients with cancer.
  • Our oncology research and development hub is anchored by our new state-of-the-art laboratories in OneHelix and the adjacent Plus Ultra Amsterdam building, both located on the Amsterdam University Medical Centre (Amsterdam UMC) campus. Our hub is firmly positioned at the heart of the Dutch research community network, creating new opportunities for our people, our science, and the patients we work to transform outcomes for.
  • Apply:
  • If you have any questions about this vacancy, our Recruitment Team Karin Raadschelders and Caroline van Oppen are happy to answer your questions. You can contact them via info@werkenbijacertapharma.nl or by phone on +31(0)85 - 047 0244.
  • We don’t work with a fixed closing date: The vacancy will remain online until we have concluded the process.
  • Please apply immediately – we start up the selection process straight away.
  • Date Posted
  • 26-May-2026
  • Closing Date
  • 08-Jun-2026
  • AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

EU Requirements

Job Details

Posted13 June 2026
Closes13 July 2026
Job TypeFull time
Work ModeOn-site

Contact

Similar Jobs

Finding similar jobs...